|
1
|
Klein CA: The metastasis cascade. Science.
321:1841–1844. 2008. View Article : Google Scholar
|
|
2
|
Mego M, Mani SA and Cristofanilli M:
Molecular mechanisms of metastasis in breast cancer – clinical
applications. Nat Rev Clin Oncol. 7:693–701. 2010.
|
|
3
|
Graves H and Czerniecki BJ: Circulating
tumor cells in breast cancer patients: an evolving role in patient
prognosis and disease progression. Pathol Res Int. 2011:6210902011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pantel K and Brakenhoff RH: Dissecting the
metastatic cascade. Nat Rev Cancer. 4:448–456. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Serrano MJ, Sánchez-Rovira P,
Delgado-Rodriguez M and Gaforio JJ: Detection of circulating tumor
cells in the context of treatment: prognostic value in breast
cancer. Cancer Biol Ther. 8:671–675. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Botteri E, Sandri MT, Bagnardi V, Munzone
E, Zorzino L, Rotmensz N, Casadio C, Cassatella MC, Esposito A,
Curigliano G, et al: Modeling the relationship between circulating
tumour cell number and prognosis of metastatic breast cancer.
Breast Cancer Res Treat. 122:211–217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin H, Balic M, Zheng S, Datar R and Cote
R: Disseminated and circulating tumor cells: role in effective
cancer management. Crit Rev Oncol Hematol. 77:1–11. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
García-Sáenz JA, Martín M, Maestro ML,
Vidaurreta M, Veganzones S, Rafael S, Casado A, Bobokova J, Sastre
J, de la Orden V, et al: Circulating tumour cells in locally
advanced breast cancer. Clin Transl Oncol. 11:544–547. 2009.
|
|
9
|
Pierga JY, Bidard FC, Mathiot C, Brain E,
Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A
and Marty M: Circulating tumor cell detection predicts early
metastatic relapse after neoadjuvant chemotherapy in large operable
and locally advanced breast cancer in a phase II randomized trial.
Clin Cancer Res. 14:7004–7010. 2008. View Article : Google Scholar
|
|
10
|
Nakagawa T, Martinez SR, Goto Y, Koyanagi
K, Kitago M, Shingai T, Elashoff DA, Ye X, Singer FR, Giuliano AE
and Hoon DSB: Detection of circulating tumor cells in early-stage
breast cancer metastasis to axillary lymph nodes. Clin Cancer Res.
13:4105–4110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wong NS, Kahn HJ, Zhang L, Oldfield S,
Yang LY, Marks A and Trudeau ME: Prognostic significance of
circulating tumour cells enumerated after filtration enrichment in
early and metastatic breast cancer patients. Breast Cancer Res
Treat. 99:63–69. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Langer R, Ott K, Feith M, Lordick F,
Siewert JR and Becker K: Prognostic significance of
histopathological tumor regression after neoadjuvant chemotherapy
in esophageal adenocarcinomas. Mod Pathol. 22:1555–1563. 2009.
View Article : Google Scholar
|
|
13
|
Makhoul I and Kiwan E: Neoadjuvant
systemic treatment of breast cancer. J Surg Oncol. 103:348–357.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pierga JY, Hajage D, Bachelot T, Delaloge
S, Brain E, Campone M, Dieras V, Rolland E, Mignot L, Mathiot C and
Bidard FC: High independent prognostic and predictive value of
circulating tumor cells compared with serum tumor markers in a
large prospective trial in first-line chemotherapy for metastatic
breast cancer patients. Ann Oncol. 2011. View Article : Google Scholar : 2011.
|
|
15
|
Riethdorf S and Pantel K: Disseminated
tumor cells in bone marrow and circulating tumor cells in blood of
breast cancer patients: current state of detection and
characterization. Pathobiology. 75:140–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gaforio JJ, Serrano MJ, Sanchez-Rovira P,
Sirvent A, Delgado-Rodriguez M, Campos M, de la Torre N, Algarra I,
Duenas R and Lozano A: Detection of breast cancer cells in the
peripheral blood is positively correlated with estrogen-receptor
status and predicts for poor prognosis. Int J Cancer. 107:984–990.
2003. View Article : Google Scholar
|
|
17
|
Bidard FC, Mathiot C, Delaloge S, Brain E,
Giachetti S, de Cremoux P, Marty M and Pierga JY: Single
circulating tumor cell detection and overall survival in
nonmetastatic breast cancer. Ann Oncol. 21:729–733. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Riethdorf S, Müller V, Zhang L, Rau T,
Komor M, Roller M, Huober J, Fehm T, Schrader I, Hilfrich J, et al:
Detection and HER2 expression of circulating tumor cells:
prospective monitoring in breast cancer patients treated in the
neoadjuvant geparquattro trial. Clin Cancer Res. 16:2634–2645.
2010. View Article : Google Scholar
|
|
19
|
Serrano MJ, Lorente JA, Delgado Rodríguez
M, Fernández A, Fernández M, de la Torre C, Fernández Izquierdo J
and Sánchez Rovira P: Circulating tumour cells in peripheral blood:
potential impact on breast cancer outcome. Clin Trans Oncol.
13:204–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pachmann K, Camara O, Kavallaris A,
Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U,
Altendorf-Hofmann A, et al: Monitoring the response of circulating
epithelial tumor cells to adjuvant chemotherapy in breast cancer
allows detection of patients at risk of early relapse. J Clin
Oncol. 26:1208–1215. 2008. View Article : Google Scholar
|
|
22
|
Pachmann K, Camara O, Kohlhase A, et al:
Assessing the efficacy of targeted therapy using circulating
epithelial tumor cells (CETC): the example of SERM therapy
monitoring as a unique tool to individualize therapy. J Cancer Res
Clin Oncol. 137:821–828. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meng S, Tripathy D, Frenkel EP, Shete S,
Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, et
al: Circulating tumor cells in patients with breast cancer
dormancy. Clin Cancer Res. 10:8152–8162. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aguirre-Ghiso JA: Models, mechanisms and
clinical evidence for cancer dormancy. Nat Rev Cancer. 7:834–846.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
